Bevacizumab and sepsis 
Bevacizumab and sepsis Patient Reports February 10, 2010
Bevacizumab Side Effects Report #5660899-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 26, 2008. Male patient was diagnosed with rectal cancer recurrent and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: intestinal obstruction, pain in extremity, sepsis
. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with IRINOTECAN HYDROCHLORIDE, FLUOROURACIL, ISOVORIN. Patient died on 11/20/2007.Bevacizumab Side Effects Report #5537257-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 26, 2007. Male patient was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: sepsis
. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with IRINOTECAN, ISOVORIN, FLUOROURACIL. Patient died.Bevacizumab Side Effects Report #5557707-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 30, 2007. Male patient was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: condition aggravated, infection
, sepsis . Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with FLUOROURACIL, ISOVORIN, OXALIPLATIN, CYTOTEC, DICLOFENAC, LOXONIN, MORPHINE ELIXIR, NORVASC. Patient died on 11/10/2007.Bevacizumab Side Effects Report #5558287-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 29, 2007. Male patient was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: intestinal obstruction, pain in extremity, sepsis
. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with IRINOTECAN, ISOVORIN, FLUOROURACIL. Patient died on 11/20/2007.Bevacizumab Side Effects Report #5571242-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 07, 2007. Male patient was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: intestinal obstruction, pain in extremity, sepsis
. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with IRINOTECAN, ISOVORIN, FLUOROURACIL. Patient died on 11/20/2007.Bevacizumab Side Effects Report #5571926-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 10, 2007. Male patient was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disease progression, sepsis
. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with FLUOROURACIL, ISOVORIN, OXALIPLATIN, CYTOTEC, DICLOFENAC, LOXONIN, MORPHINE ELIXIR, NORVASC. Patient died on 11/10/2007.Bevacizumab Side Effects Report #6130320-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Mar 16, 2009. Male patient, weighting 200.0 lb, was diagnosed with rectal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acute respiratory failure, myocardial infarction, sepsis
. Bevacizumab dosage: 5 MG/KG, DAYS 1+15. During the same period patient was treated with FLUOROURACIL, RADIATION. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5595622-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 16, 2008. Male patient, 73 years of age, weighting 205.0 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: bile duct obstruction, cholangitis, sepsis
. Bevacizumab dosage: 930MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient was hospitalized and became disabled. Patient recovered.Bevacizumab Side Effects Report #5743372-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on May 15, 2008. Female patient, 62 years of age, weighting 132.3 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: catheter site infection, cerebrovascular accident, hypotension, movement disorder
, sepsis . Bevacizumab dosage: 610 MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient was hospitalized and became disabled. Patient recovered.Bevacizumab Side Effects Report #5523995-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 09, 2007. Female patient was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: sepsis
. Bevacizumab dosage: 550 MG, UNK. During the same period patient was treated with DOCETAXEL, GEMCITABINE. Patient was hospitalized. Patient died on 11/08/2007.Bevacizumab Side Effects Report #5938599-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 24, 2008. Male patient, weighting 154.3 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: sepsis
. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with ERLOTINIB, GEMZAR, TAMSULOSIN, LACTULOSE, TRAZOLAN, TRAMADOL, VOLTAREN, ZANTAC. Patient was hospitalized. Patient died on 11/20/2006.Bevacizumab Side Effects Report #5938600-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 27, 2008. Female patient, weighting 130.1 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: sepsis
. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with ERLOTINIB, GEMCITABINE, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5947528-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 27, 2008. Male patient, weighting 136.7 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pyrexia, sepsis
. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with ERLOTINIB, GEMCITABINE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5546335-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 06, 2007. Female patient, 31 years of age, weighting 161.6 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hydronephrosis, inadequate analgesia, sepsis
, small intestinal obstruction. Bevacizumab dosage: 10 MG/KG IV DRIP. During the same period patient was treated with TOPOTECAN GSK, ACETAMINOPHEN, BISCODYL, DILAUDID, BUPIVACAINE, DIPHENHYDRAMINE, ERTAPENEM, ESTRADIOL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5557745-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 06, 2007. Female patient, 31 years of age, weighting 161.6 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: hydronephrosis, malignant neoplasm progression, ovarian cancer, pain
, sepsis , small intestinal obstruction. Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with TOPOTECAN, DILAUDID, ACETAMINOPHEN, BISACODYL, DIPHENHYDRAMINE, ERTAPENEM, FAT EMULSION, FENTANYL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5599815-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 18, 2008. Female patient, 31 years of age, weighting 161.6 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, convulsion, hydronephrosis, inadequate analgesia, malignant neoplasm progression, sepsis . Bevacizumab dosage: 10 MG/KG INTRAVENOUS DRIP. During the same period patient was treated with TOPOTECAN GSK, ACETAMINOPHEN, BISCODYL, DILAUDID, BUPIVACAINE, EPIDURAL, DIPHENHYDRAMINE, ERTAPENEM. Patient died on 01/09/2008.Bevacizumab Side Effects Report #5595193-7
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 10, 2008. Male patient, weighting 156.5 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain upper, atrial fibrillation
, dehydration, sepsis . Bevacizumab dosage: 15 MG/KG, DAYS 1+22. During the same period patient was treated with ERLOTINIB, FLUOROURACIL, CARBOPLATIN, PACLITAXEL, OXYCODONE, VALIUM. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5601543-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 17, 2008. Male patient, weighting 156.5 lb, was diagnosed with oesophageal carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain upper, atrial fibrillation
, dehydration, sepsis . Bevacizumab dosage: 15 MG/KG, DAYS 1+22. During the same period patient was treated with ERLOTINIB, FLUOROURACIL, CARBOPLATIN, PACLITAXEL, PROTONIX, LORTAB, OXYCODONE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5301509-9
Bevacizumab side effect was reported by a Physician from UNITED STATES on Apr 17, 2007. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, nausea , pneumonia , sepsis . Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with DOCETAXEL, OXALIPLATIN, SINGULAIR, DEXAMETHASONE, FLUCONAZOLE, ATIVAN, LISINOPRIL, COMPAZINE. Patient was hospitalized. Patient died on 02/08/2007.Bevacizumab Side Effects Report #5312790-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Apr 23, 2007. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, nausea , pneumonia , sepsis . Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with DOCETAXEL, OXALIPLATIN, SINGULAIR, DEXAMETHASONE, FLUCONAZOLE, ATIVAN, LISINOPRIL, COMPAZINE. Patient was hospitalized. Patient died on 02/08/2007.Bevacizumab Side Effects Report #5363507-9
Bevacizumab side effect was reported by a Physician from UNITED STATES on June 12, 2007. Female patient, weighting 134.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, sepsis
. Bevacizumab dosage: 913 MG, Q3W. During the same period patient was treated with CARBOPLATIN, TAXOL. Patient died on 06/10/2007.Bevacizumab Side Effects Report #5392590-X
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 12, 2007. Female patient, weighting 134.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, sepsis
. Bevacizumab dosage: 913 MG, Q3W. During the same period patient was treated with CARBOPLATIN, TAXOL. Patient died on 06/10/2007.Bevacizumab Side Effects Report #5396749-7
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 19, 2007. Female patient, weighting 134.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: sepsis
. Bevacizumab dosage: 913 MG, Q3W. During the same period patient was treated with CARBOPLATIN, TAXOL. Patient died on 06/10/2007.Bevacizumab Side Effects Report #5445043-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Aug 27, 2007. Male patient, weighting 163.4 lb, was diagnosed with non-small cell lung cancer, hypertension, chronic obstructive pulmonary disease, iron deficiency, musculoskeletal chest pain and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: sepsis
. Bevacizumab dosage: 1110 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, LOTENSIN, ADVAIR DISKUS, ALBUTEROL, NORVASC, FEOSOL, VICODIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5701286-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 26, 2008. Male patient, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: circulatory collapse, diarrhoea, disease progression, peritonitis, sepsis
, vomiting. Bevacizumab dosage: 945 MG, Q3W. During the same period patient was treated with CARBOPLATIN, VINORELBINE, OMEPRAZOLE, NOVAMINSULFON, LAXOBERAL, MS CONTIN, SEVREDOL. Patient was hospitalized. Patient died on 06/01/2007.Bevacizumab Side Effects Report #5741087-3
Bevacizumab side effect was reported by a Physician from GERMANY on Feb 14, 2008. Male patient, weighting 143.3 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: sepsis
. Bevacizumab dosage: 1035 MG, Q3W. During the same period patient was treated with NULYTELY, FENTANYL CITRATE, ACETYLCYSTEINE, OMEPRAZOLE, RAMIPRIL, VIANI, NOVAMINSULFON. Patient was hospitalized. Patient died on 01/22/2008.Bevacizumab Side Effects Report #5775925-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 21, 2008. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, sepsis
. Bevacizumab dosage: 430 MG, TID. During the same period patient was treated with CISPLATIN, GEMCITABINE. Patient was hospitalized. Patient died on 05/17/2008.Bevacizumab Side Effects Report #5839080-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on Aug 01, 2008. Male patient, weighting 207.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: constipation
, intestinal perforation, sepsis . Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with ALIMTA, CARBOPLATIN, FOLIC ACID, ACIPHEX, SENOKOT. Patient died on 07/22/2008.Bevacizumab Side Effects Report #5888016-X
Bevacizumab side effect was reported by a Physician from UNITED STATES on Sept 10, 2008. Male patient, weighting 207.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: constipation
, intestinal perforation, sepsis . Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with ALIMTA, CARBOPLATIN, FOLIC ACID, ACIPHEX, SENOKOT. Patient died on 07/22/2008.Bevacizumab Side Effects Report #5888604-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 05, 2008. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, sepsis
. Bevacizumab dosage: 430 MG, Q3W. During the same period patient was treated with CISPLATIN, GEMCITABINE. Patient was hospitalized. Patient died on 05/17/2008.Bevacizumab Side Effects Report #5952405-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on Nov 05, 2008. Male patient, weighting 207.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: constipation
, intestinal perforation, sepsis . Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with ALIMTA, CARBOPLATIN, FOLIC ACID, ACIPHEX, SENOKOT. Patient died on 07/22/2008.Bevacizumab Side Effects Report #5957210-1
Bevacizumab side effect was reported by a Physician from UNITED STATES on Nov 12, 2008. Male patient, weighting 207.2 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: constipation
, intestinal perforation, sepsis . Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with ALIMTA, CARBOPLATIN, FOLIC ACID, ACIPHEX, SENOKOT. Patient died on 07/22/2008.Bevacizumab Side Effects Report #5977890-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Nov 25, 2008. Male patient, weighting 174.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acidosis, atrial fibrillation
, diarrhoea, sepsis , vomiting. Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with PEMETREXED, GEMCITABINE. Patient was hospitalized. Patient died on 11/25/2008.Bevacizumab Side Effects Report #6049470-6
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 16, 2009. Male patient, weighting 174.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acidosis, atrial fibrillation
, diarrhoea, sepsis , vomiting. Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with PEMETREXED, GEMCITABINE, LANOXIN, METOPROLOL TARTRATE, MAG OXIDE, PREDNISONE, ALPRAZOLAM, GLUCOSAMINE. Patient was hospitalized. Patient died on 11/25/2008.Bevacizumab Side Effects Report #6055821-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 16, 2009. Male patient, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: circulatory collapse, diarrhoea, disease progression, peritonitis, sepsis
, vomiting. Bevacizumab dosage: 945 MG, Q3W. During the same period patient was treated with CARBOPLATIN, VINORELBINE, OMEPRAZOLE, NOVAMINSULFON, LAXOBERAL, MS CONTIN, MORPHINE, ONDANSETRON. Patient was hospitalized. Patient died on 06/01/2007.Bevacizumab Side Effects Report #6062745-X
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 26, 2009. Male patient, weighting 156.5 lb, was diagnosed with non-small cell lung cancer, gastrooesophageal reflux disease, prophylaxis, nausea
, pain and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pneumothorax, respiratory distress, respiratory failure, sepsis . Bevacizumab dosage: 15 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, OMEPRAZOLE, CEFTAZIDIME, ASPIRIN, ONDANSETRON HYDROCHLORIDE, MORPHINE. Patient died on 01/25/2009.Bevacizumab Side Effects Report #6086396-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 12, 2009. Male patient, weighting 193.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, haematocrit decreased, intestinal obstruction, intestinal perforation, platelet count increased, pneumoperitoneum, sepsis
. Bevacizumab dosage: 875 MG, UNK. During the same period patient was treated with GEMCITABINE, PACLITAXEL, ASPIRIN, COMBIVENT, LIPITOR, ZEBETA, ZYRTEC, ZOFRAN. Patient was hospitalized. Patient died on 02/08/2009.Bevacizumab Side Effects Report #6097741-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 19, 2009. Male patient, weighting 193.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: intestinal obstruction, intestinal perforation, sepsis
. Bevacizumab dosage: 875 MG, UNK. During the same period patient was treated with GEMCITABINE, PACLITAXEL, ASPIRIN, COMBIVENT, LIPITOR, ZEBETA, ZYRTEC, ZOFRAN. Patient was hospitalized. Patient died on 02/08/2009.Bevacizumab Side Effects Report #5989594-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 26, 2008. Male patient was diagnosed with malignant lymphoid neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: respiratory failure, sepsis
. Bevacizumab dosage: unknown. During the same period patient was treated with CYTARABINE, METFORMIN, SIMVASTATIN, IMIPENEM, ESOMEPRAZOLE MAGNESIUM, HALOPERIDOL, ACETAMINOPHEN. Patient died on 11/26/2008.Bevacizumab Side Effects Report #5150552-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 09, 2006. Male patient, 59 years of age, weighting 184.3 lb, was diagnosed with laryngeal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acute hepatic failure, acute myocardial infarction, hypoglycaemia, pneumonia aspiration, renal failure acute, sepsis
, septic shock, sputum culture positive. Bevacizumab dosage: 361 MG IV. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5151170-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 14, 2006. Male patient, 59 years of age, weighting 184.3 lb, was diagnosed with laryngeal cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: bacillus infection, hepatic failure, hypoglycaemia, pneumonia aspiration, sepsis
, septic shock, sputum culture positive. Bevacizumab dosage: 361 MG IV. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5394707-X
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 16, 2007. Male patient was diagnosed with hepatic neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: encephalopathy, sepsis
. Bevacizumab dosage: 5 MG/KG, Q3W. During the same period patient was treated with OXALIPLATIN, XELODA, PROTONIX, LACTULOSE, MICRO, RIFAXIMIN. Patient died on 02/23/2007.Bevacizumab Side Effects Report #6009196-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 17, 2006. Male patient was diagnosed with hepatic neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: encephalopathy, sepsis
. Bevacizumab dosage: 355 MG, UNK. Patient was hospitalized. Patient died on 09/30/2006.Bevacizumab Side Effects Report #5046127-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 07, 2006. Male patient, weighting 207.2 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: bacterial infection
, catheter related infection, diarrhoea, platelet count decreased, pyrexia, sepsis . Bevacizumab dosage: 947MG QOW IV. During the same period patient was treated with IRINOTECAN, DILANTIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4752179-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 24, 2005. Male patient, 24 years of age, weighting 158.7 lb, was diagnosed with gastrooesophageal cancer, metastasis and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: bacterial infection
, blood culture positive, chest x-ray abnormal, false positive laboratory result, neutropenia, pharyngolaryngeal pain, pyrexia, sepsis , vomiting. Bevacizumab dosage: 15MG/KG IV DL EVERY 21D. During the same period patient was treated with OXALIPLATIN, DOCETAXEL, LEXAPRO, ZITHROMAX, CARAFATE, LORTAB. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5299026-8
Bevacizumab side effect was reported by a Physician from UNITED STATES on Apr 11, 2007. Female patient, weighting 119.0 lb, was diagnosed with gallbladder cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acute myocardial infarction, aortic arteriosclerosis, culture urine positive, mitral valve incompetence, sepsis . Bevacizumab dosage: 10 MG, 2/MONTH. During the same period patient was treated with GEMCITABINE, OXALIPLATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5314643-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 18, 2007. Male patient, weighting 184.1 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: sepsis
. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, TOPROL, PLAVIX, ASPIRIN, LOTREL, LIPITOR, METFORMIN. Patient was hospitalized. Patient died on 04/16/2007.Bevacizumab Side Effects Report #5390631-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on July 04, 2007. Female patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: arteriospasm coronary, intestinal obstruction, pulmonary embolism
, sepsis . Bevacizumab dosage: 510 MG, UNK. During the same period patient was treated with XELODA, NEXIUM, ACTONEL, TEMAZEPAM, ASPIRIN, SOLPRIN, PARIET, SALBUTAMOL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5413586-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 06, 2007. Male patient, weighting 159.0 lb, was diagnosed with colorectal cancer metastatic, atrial fibrillation
, hypertension, dyspepsia and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: paraneoplastic syndrome, sepsis . Bevacizumab dosage: 385.5 MG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, COUMADIN, COZAAR, CARDIZEM, PEPCID. Patient died on 07/31/2007.Bevacizumab Side Effects Report #5449426-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 27, 2007. Male patient, weighting 159.0 lb, was diagnosed with colorectal cancer metastatic, atrial fibrillation
, hypertension, dyspepsia and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: sepsis . Bevacizumab dosage: 385.5 MG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, COUMADIN, COZAAR, CARDIZEM, PEPCID. Patient died on 07/31/2007.Bevacizumab Side Effects Report #5467474-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 14, 2007. Male patient, weighting 159.0 lb, was diagnosed with colorectal cancer metastatic, atrial fibrillation
, hypertension, dyspepsia and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: paraneoplastic syndrome, sepsis . Bevacizumab dosage: 385.5 MG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN, COUMADIN, COZAAR, CARDIZEM, PEPCID. Patient died on 07/31/2007.Bevacizumab Side Effects Report #5606884-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 22, 2008. Female patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: sepsis
. Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with ERBITUX, LEUCOVORIN CALCIUM, OXALIPLATIN, FLUOROURACIL. Patient was hospitalized. Patient died on 01/06/2008.Bevacizumab Side Effects Report #5781124-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on June 06, 2008. Male patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, renal failure acute, sepsis
. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN, IMATINIB MESILATE. Patient recovered.Bevacizumab Side Effects Report #5830872-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 24, 2008. Male patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: paraneoplastic syndrome, sepsis
. Bevacizumab dosage: 385.5 MG, Q2W. During the same period patient was treated with OXALIPLATIN, FOLINIC ACID, FLUOROURACIL, COUMADIN, COZAAR, CARDIZEM, PEPCID. Patient was hospitalized. Patient died on 07/31/2007.Bevacizumab Side Effects Report #5851801-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 06, 2008. Female patient, weighting 164.9 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, haematemesis, mucosal inflammation, sepsis . Bevacizumab dosage: 562.5 MG, Q3W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, PHILLIPS, LORTAB, FISH OIL, TYLENOL, AVANDIA, ACIPHEX. Patient was hospitalized. Patient died on 11/20/2007.Bevacizumab Side Effects Report #5854264-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 08, 2008. Male patient, weighting 147.7 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, renal failure acute, sepsis
. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN, IMATINIB MESILATE. Patient recovered.Bevacizumab Side Effects Report #5918199-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 01, 2008. Male patient, weighting 147.7 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, renal failure acute, sepsis
. Bevacizumab dosage: 5 MG/KG, QD. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN, IMATINIB MESILATE, HEPARIN. Patient recovered.Bevacizumab Side Effects Report #6053890-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 20, 2009. Male patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: paraneoplastic syndrome, sepsis
. Bevacizumab dosage: 385.5 MG, Q2W. During the same period patient was treated with OXALIPLATIN, FOLINIC ACID, FLUOROURACIL, COUMADIN, COZAAR, CARDIZEM, PEPCID. Patient was hospitalized. Patient died on 07/31/2007.Bevacizumab Side Effects Report #6085733-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Feb 05, 2009. Male patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: dehydration, sepsis
. Bevacizumab dosage: unknown. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, BETAMETHASONE, PALONOSETRON, MAGNESIUM SULPHATE, CALCIUM GLUCONATE. Patient was hospitalized. Patient died on 08/18/2008.Bevacizumab Side Effects Report #5283868-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Mar 19, 2007. Female patient, 63 years of age, was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diarrhoea, infection , sepsis . Bevacizumab dosage: 450 MG, UNK. During the same period patient was treated with CAPECITABINE, IRINOTECAN. Patient was hospitalized. Patient died on 03/19/2007.Bevacizumab Side Effects Report #5375522-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on June 15, 2007. Male patient, weighting 142.6 lb, was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: sepsis . Bevacizumab dosage: 325 MG, Q2W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, ASPIRIN. Patient was hospitalized. Patient died on 06/16/2007.Bevacizumab Side Effects Report #5389581-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on July 02, 2007. Male patient, weighting 142.6 lb, was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: sepsis . Bevacizumab dosage: 325 MG, Q2W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, ASPIRIN. Patient was hospitalized. Patient died on 06/16/2007.Bevacizumab Side Effects Report #5420839-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on Aug 10, 2007. Male patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: sepsis . Bevacizumab dosage: 1385.5 MG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, FOLINIC ACID, COUMADIN, COZAAR, CARDIZEM, PEPCID. Patient was hospitalized. Patient died on 07/31/2007.Bevacizumab Side Effects Report #5444014-1
Bevacizumab side effect was reported by a Physician from UNITED STATES on Aug 28, 2007. Male patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: paraneoplastic syndrome, sepsis . Bevacizumab dosage: 1385.5 MG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, FOLINIC ACID, COUMADIN, COZAAR, CARDIZEM, PEPCID. Patient was hospitalized. Patient died on 07/31/2007.Bevacizumab Side Effects Report #5467463-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Sept 14, 2007. Male patient was diagnosed with colorectal cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: sepsis . Bevacizumab dosage: 1385.5 MG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, FOLINIC ACID, COUMADIN, COZAAR, CARDIZEM, PEPCID. Patient was hospitalized. Patient died on 07/31/2007.Bevacizumab Side Effects Report #5916985-8
Bevacizumab side effect was reported by a Physician from UNITED STATES on Oct 08, 2008. Male patient, weighting 200.4 lb, was diagnosed with colorectal cancer
, hypertension, pain , nausea , cough, rash and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: sepsis . Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with LEUCOVORIN CALCIUM, FLUOROURACIL, DIOVAN, LORTAB, COMPAZINE, TUSSINEX, CLINDAMYCIN. Patient was hospitalized and became disabled. Patient died on 03/03/2008.Bevacizumab Side Effects Report #5403211-1
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 17, 2007. Female patient, 53 years of age, weighting 140.0 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, asthenia, dehydration, ileus, intestinal perforation, nausea
, oral intake reduced, sepsis , small intestinal obstruction. Bevacizumab dosage: 5MG/KG Q2W IV. During the same period patient was treated with COUMADIN, PROZAC, SYNTHROID, VICODIN, COMPAZINE. Patient was hospitalized. Patient died on 06/30/2007.Bevacizumab Side Effects Report #5710141-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 03, 2008. Male patient, weighting 149.9 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: colonic fistula, gastrointestinal necrosis, sepsis
. Bevacizumab dosage: unknown. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5724950-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Apr 22, 2008. Female patient, weighting 129.0 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: neutropenia, respiratory failure, sepsis
. Bevacizumab dosage: 300 MG, Q2W. During the same period patient was treated with FLUOROURACIL, OXALIPLATIN, LEUCOVORIN CALCIUM, CIPROFLOXACIN, TENORMIN, CLONIDINE, HYZAAR. Patient was hospitalized. Patient died on 03/29/2008.Bevacizumab Side Effects Report #5320863-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 26, 2007. Female patient, weighting 179.0 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: sepsis
. Bevacizumab dosage: 1242 MG, Q3W. During the same period patient was treated with TAXOTERE, LEVOTHYROXINE, ZOFRAN, FORTECORTIN, ACEMIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5411437-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on July 27, 2007. Female patient, weighting 152.1 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, haemoptysis, sepsis
. Bevacizumab dosage: 1065 MG, Q3W. During the same period patient was treated with PACLITAXEL, LOSARTAN POTASSIUM, DILTIAZEM, SALMETEROL, FLUTICASONE PROPIONATE, HIDROXIZINA, DIOSMIN, MORPHINE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5452719-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 30, 2007. Female patient, weighting 152.1 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, haemoptysis, klebsiella infection, sepsis
. Bevacizumab dosage: 1065 MG, Q3W. During the same period patient was treated with PACLITAXEL, LOSARTAN POSTASSIUM, DILTIAZEM, SALMETEROL, FLUTICASONE PROPIONATE, HIDROXIZINA, DIOSMIN, MORPHINE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5518216-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 31, 2007. Female patient, weighting 152.1 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, haemoptysis, sepsis
. Bevacizumab dosage: 1065 MG, Q3W. During the same period patient was treated with PACLITAXEL, LOSARTAN POTASSIUM, DILTIAZEM, SALMETEROL, FLUTICASONE PROPIONATE, HIDROXIZINA, DIOSMIN, MORPHINE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5603070-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 18, 2008. Female patient, weighting 169.0 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: sepsis
. Bevacizumab dosage: 1550 MG, Q3W. During the same period patient was treated with ABRAXANE. Patient died on 12/05/2007.Bevacizumab Side Effects Report #5692080-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Mar 18, 2008. Female patient, weighting 154.3 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, haemoptysis, sepsis
. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with IPRATROPIUM, DEXAMETHASONE, CALCIUM SANDOZ, FENTANYL, ACETAMINOPHEN. Patient died on 03/09/2008.Bevacizumab Side Effects Report #5718563-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 11, 2008. Female patient, weighting 208.6 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: pyrexia, sepsis
. Bevacizumab dosage: 1485 MG, Q3W. During the same period patient was treated with DOCETAXEL, ZOLEDRONIC ACID. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5887041-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 04, 2008. Female patient, weighting 154.3 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, haemoptysis, sepsis
. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with IPRATROPIUM, DEXAMETHASONE, CALCIUM SANDOZ, FENTANYL, ACETAMINOPHEN. Patient died on 03/09/2008.Bevacizumab Side Effects Report #5918207-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 30, 2008. Female patient, weighting 154.3 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, haemoptysis, sepsis
. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with IPRATROPIUM, DEXAMETHASONE, CALCIUM SANDOZ, FENTANYL, ACETAMINOPHEN. Patient died on 03/09/2008.Bevacizumab Side Effects Report #5919709-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 07, 2008. Female patient, weighting 196.2 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: sepsis
. Bevacizumab dosage: 886 MG, UNK. During the same period patient was treated with ABRAXANE, GEMZAR. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5930248-6
Bevacizumab side effect was reported by a Physician from MALAYSIA on Oct 17, 2008. Female patient, weighting 112.4 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: necrotising fasciitis, pneumonia aspiration, post procedural haemorrhage, postoperative abscess, sepsis
. Bevacizumab dosage: 780 MG, Q3W. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5443251-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 31, 2007. Female patient, 65 years of age, weighting 192.0 lb, was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: atrial fibrillation , bronchitis , laryngitis, mental status changes, sepsis , sinusitis , vomiting. Bevacizumab dosage: 15MG/KG Q3WKS (IV). During the same period patient was treated with CYCLOPHOSPHAMIDE, METHOTREXATE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5725755-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on Apr 24, 2008. Female patient, 49 years of age, weighting 198.4 lb, was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: sepsis . Bevacizumab dosage: unknown. During the same period patient was treated with DOCETAXEL, CYCLOPHOSPHAMIDE, DOXORUBICIN, ZANTAC, SYNTHROID, FOSAMAX, SENOKOT, CALCIUM. Patient died on 06/29/2007.Bevacizumab Side Effects Report #5547342-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Dec 03, 2007. Female patient, weighting 158.0 lb, was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: alpha haemolytic streptococcal infection, atelectasis, deep vein thrombosis , dyspnoea, groin abscess, haemoglobin decreased, sepsis , ulcer . Bevacizumab dosage: 5 MG/KG, UNK. During the same period patient was treated with TRASTUZUMAB, CARBOPLATIN, PACLITAXEL, PROTONIX, WELLBUTRIN, ASPIRIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5697659-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Mar 25, 2008. Female patient, weighting 207.2 lb, was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: sepsis . Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with HERCEPTIN, DOCETAXEL, SERTRALINE, DIPIRONE, MORPHINE, OMEPRAZOLE. Patient was hospitalized. Patient died on 03/22/2008.Bevacizumab Side Effects Report #5697661-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Mar 25, 2008. Female patient, weighting 207.2 lb, was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: sepsis . Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with HERCEPTIN, DOCETAXEL, SERTRALINE, DIPIRONE, MORPHINE, OMEPRAZOLE. Patient was hospitalized. Patient died on 03/22/2008.Bevacizumab Side Effects Report #5722635-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 17, 2008. Female patient, weighting 207.2 lb, was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: sepsis . Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with HERCEPTIN, DOCETAXEL, SERTRALINE, DIPIRONE, MORPHINE, OMEPRAZOLE. Patient was hospitalized. Patient died on 03/22/2008.Bevacizumab Side Effects Report #5722659-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 17, 2008. Female patient, weighting 207.2 lb, was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: sepsis . Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with HERCEPTIN, DOCETAXEL, SERTRALINE, DIPIRONE, MORPHINE, OMEPRAZOLE. Patient was hospitalized. Patient died on 03/22/2008.Bevacizumab Side Effects Report #5744353-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 06, 2008. Female patient, weighting 207.2 lb, was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, sepsis . Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with HERCEPTIN, DOCETAXEL, SERTRALINE, DIPIRONE, MORPHINE, OMEPRAZOLE. Patient was hospitalized. Patient died on 03/22/2008.Bevacizumab Side Effects Report #5744354-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 06, 2008. Female patient, weighting 207.2 lb, was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, body temperature decreased, febrile neutropenia, leukopenia, sepsis , septic shock. Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with HERCEPTIN, DOCETAXEL, SERTRALINE, DIPIRONE, MORPHINE, OMEPRAZOLE. Patient was hospitalized. Patient died on 03/22/2008.Bevacizumab Side Effects Report #5762591-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 27, 2008. Female patient, weighting 207.2 lb, was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, sepsis . Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with HERCEPTIN, DOCETAXEL, SERTRALINE, DIPIRONE, MORPHINE, OMEPRAZOLE. Patient was hospitalized. Patient died on 03/22/2008.Bevacizumab Side Effects Report #5762592-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 27, 2008. Female patient, weighting 207.2 lb, was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, sepsis . Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with HERCEPTIN, DOCETAXEL, SERTRALINE, DIPIRONE, MORPHINE, OMEPRAZOLE. Patient was hospitalized. Patient died on 03/22/2008.Bevacizumab Side Effects Report #5872308-4
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 21, 2008. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diverticulitis, sepsis . Bevacizumab dosage: 1350 MG, UNK. During the same period patient was treated with EPIRUBICIN, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5952532-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Sept 17, 2008. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: diverticulitis, sepsis . Bevacizumab dosage: 1350 MG, UNK. During the same period patient was treated with EPIRUBICIN, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5953948-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 30, 2008. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: bone marrow failure, leukopenia, pseudomonas infection, sepsis . Bevacizumab dosage: 470 MG, UNK. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5994549-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 27, 2008. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: bone marrow failure, sepsis . Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with EPIRUBICIN, CYCLOPHOSPHAMIDE, PACLITAXEL, METOPROLOL, DISALUNIL, RUDOTEL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #6077706-4
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 03, 2009. Female patient was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: bone marrow failure, sepsis . Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with EPIRUBICIN, CYCLOPHOSPHAMIDE, PACLITAXEL, METOPROLOL TARTRATE, DISALUNIL, RUDOTEL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5800841-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on June 20, 2008. Female patient was diagnosed with acute myeloid leukaemia and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: arrhythmia
, ileus, infection , sepsis . Bevacizumab dosage: 600 MG, DAYS 1+15. During the same period patient was treated with CYTARABINE, TORSEMIDE, BISOPROLOL FUMARATE, LISINOPRIL, AMLODIPINE BESYLATE, METRONIDAZOLE, CEFEPIME. Patient recovered.Bevacizumab Side Effects Report #5811573-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 03, 2008. Female patient was diagnosed with acute myeloid leukaemia and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: arrhythmia
, ileus, infection , sepsis . Bevacizumab dosage: 600 MG, DAYS 1+15. During the same period patient was treated with CYTARABINE, TORSEMIDE, BISOPROLOL FUMARATE, LISINOPRIL, AMLODIPINE BESYLATE, METRONIDAZOLE, CEFEPIME. Patient recovered.Bevacizumab Side Effects Report #5834725-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 10, 2008. Female patient was diagnosed with acute myeloid leukaemia and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: arrhythmia
, ileus, infection , sepsis . Bevacizumab dosage: 600 MG, DAYS 1+15. During the same period patient was treated with CYTARABINE, TORSEMIDE, BISOPROLOL FUMARATE, LISINOPRIL, AMLODIPINE BESYLATE, METRONIDAZOLE, CEFEPIME. Patient recovered.Bevacizumab Side Effects Report #5863085-1
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 13, 2008. Female patient was diagnosed with acute myeloid leukaemia and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: arrhythmia
, ileus, infection , sepsis . Bevacizumab dosage: 600 MG, DAYS 1+15. During the same period patient was treated with CYTARABINE, TORSEMIDE, BISOPROLOL FUMARATE, LISINOPRIL, AMLODIPINE BESYLATE, METRONIDAZOLE, CEFEPIME. Patient recovered.